RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older ...

mRNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older ...

mRNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older ...

mRNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older ...

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

Apr. 23, 2025 — A vaccine under development has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu. The work focuses on the H5N1 variant known as ...

Latest medical research on cold and flu viruses, including symptoms, remedies, prevention and treatment. Learn how you can help protect yourself from cold and flu viruses, including swine flu and ...

The V-670 double-beam spectrophotometer utilizes a unique, single monochromator design covering a wavelength range from 190 to 2700 nm (3200 nm option). The monochromator features dual gratings ...

The V-650 is a double-beam spectrophotometer with a photomultiplier tube (PMT) detector. The high sensitivity of the PMT enables accurate measurements of low (and high) concentration samples. By ...